AstraZeneca's said its COVID-19 vaccine was 76% effective in a new analysis of its U.S. trial - only a tad lower than the level in an earlier report this week criticised for using outdated data.
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en